Lilly noted in a press release announcing Foundayo’s FDA approval that adults on the highest dose of the medication lost an ...

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...

The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight ...

The FDA on approved Eli Lilly's weight-loss pill, setting ​up its next battle with rival Novo Nordisk for the millions of ...

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill ...

A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved ...

Whether they’re using weekly shots or daily pills, more Americans than ever are turning to anti-obesity drugs to lose weight ...

In fact, one of the big fears among people taking GLP-1 agonists (the class of drug to which Ozempic belongs) is that they’ll ...

The weight-loss drugs that took the world by storm a few years ago have a drawback for anyone afraid of needles: they must be injected weekly. But scientists have been racing to perfect anti-obesity ...

What if you could get the mental health benefits of exercise… without working out? Scientists are exploring “exercise mimetics,” compounds that may activate the same powerful brain-boosting signals ...

Sen. Josh Hawley (R-Mo.) is once again spreading misinformation about the abortion pill mifepristone, and has taken his campaign a step further by introducing legislation to ban it. The Safeguarding ...